Clinical Trial Update: Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol [Phase 4]

View source ↗

Summary

Phase 4 trial assessing ezetimibe's effect on oxidized LDL cholesterol in patients with coronary artery disease and diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• Zetia (ezetimibe)

Snippet

Sponsor: Hotel Dieu de France Hospital | Conditions: Coronary Artery Disease, Diabetes | Phase 4 | Status: COMPLETED